Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
&NA; The present study aimed to develop vitamin C based nanovesicles (aspasomes) loaded with the antioxidant melatonin, as a novel cosmeceutical to be used for clinical treatment of androgenic alopecia (AGA). Aspasomes were assessed regarding their particle size, charge, drug entrapment, anti‐oxidant potential, physical stability, in vitro release, surface morphology, and ex‐vivo skin deposition. Clinically, melatonin aspasomes were tested on AGA patients, and assessed by evaluating the degree of improvement through conduction of hair pull test, histometric analysis and dermoscopic evaluation. Results revealed that melatonin aspasomes showed favorable pharmaceutical properties in addition to clinically promising results compared to melatonin solution, manifested by increased hair thickness, density and decreased hair loss, with photographic improvement in most patients. Therefore, melatonin vitamin C‐based aspasomes were clinically auspicious in the treatment of AGA, hence, paving the way for their further exploration in other oxidative‐dependent dermatological diseases. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasr, M. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1092619 · Cited by 208 · cited 1×
“The percentage of DPPH scavenged is calculated using the following equation (Nasr, 2016): = − × DPPH Scavenged (”
MethodSelf-citation
Cited by
Lamie, C., Elmowafy, E., Attia, D. A., Elmazar, M. M., & Mortada, N. D. (2022) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2022.102561 · Cited by 29
Recent Formulation Advances of Mangiferin
Barakat, S., Nasr, M., Ahmed, R. F., Badawy, S., & Mortada, N. (2022) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-022-00297-z · Cited by 28
“Lipid-based carriers have been proven safe and efficient for the formulation of nutraceuticals (Muller et al. 2002; Hatem et al. 2018a, 2018b) due to their high degree of biocompatibility.”
BackgroundSelf-citationMicronutrients and Androgenetic Alopecia: A Systematic Review
Wang, R., Lin, J., Liu, Q., Wu, W., Wu, J., & Liu, X. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400652 · Cited by 14
A review on formulation and analytical aspect of mangiferin a natural phenolic xanthonoid
Shaikh, I., & Tatapudi, H. K. (2025) · Discover Chemistry · doi:10.1007/s44371-025-00193-0 · Cited by 3
Metadata
- Authors
- Hatem, S., Nasr, M., Moftah, N. H., Ragai, M. H., Geneidi, A. S., & Elkheshen, S. A.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 122
- Pages
- 246-253
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2820618738
- Cited by
- 72
- References
- 1
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal. https://app.cochat.ai/papers/10.1016/j.ejps.2018.06.034
- The paper
- Hatem, S., Nasr, M., Moftah, N. H., Ragai, M. H., Geneidi, A. S., & Elkheshen, S. A. (2018). Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2018.06.034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.